**Patient Discharge Summary**

**Patient Information:**

* Name: John Doe
* Date of Admission: March 10, 2023
* Date of Discharge: March 25, 2023
* Age: 25 years old
* Sex: Male
* Contact Information: [insert contact information]

**Admission and Initial Assessment:**

John Doe was admitted to the endocrinology unit on March 10, 2023, with a chief complaint of polyuria, polydipsia, and blurred vision. He presented with a 2-week history of increasing thirst and hunger, with a recent onset of nocturia. His physical examination was remarkable for dry mucous membranes, ketotic breath odor, and a negative funduscopic examination. Laboratory results revealed a fasting plasma glucose (FPG) level of 450 mg/dL (25 mmol/L) and a glycosylated hemoglobin (HbA1C) level of 13.4%.

**Diagnosis and Treatment:**

Based on the patient's symptoms, physical examination, and laboratory results, a diagnosis of type 1 diabetes mellitus was made. The patient was started on insulin therapy, with a basal-bolus regimen consisting of:

* Lantus (insulin glargine): 20 units subcutaneously at 8:00 pm
* Humalog (insulin lispro): 10 units subcutaneously before each meal (breakfast, lunch, and dinner)

The patient was also prescribed metformin 500 mg orally twice daily for weight-neutral glycemic control and to improve insulin sensitivity.

**Course of Hospitalization:**

During his hospital stay, John Doe received education on diabetes management, including diet, exercise, and medication. He was instructed on the importance of monitoring his blood glucose levels and adjusting his insulin doses accordingly. The patient was also advised on the prevention and management of hypoglycemia and hyperglycemia.

**Complications and Interventions:**

The patient did not develop any significant complications during his hospital stay. However, he did experience one episode of mild hypoglycemia, which was treated with 15 grams of glucose administered orally.

**Discharge Plan:**

John Doe was discharged from the hospital on March 25, 2023, with the following discharge instructions:

* Continue insulin therapy as prescribed
* Monitor blood glucose levels regularly and adjust insulin doses accordingly
* Follow a balanced diet with a focus on whole foods and high-quality carbohydrates
* Engage in regular physical activity, aiming for at least 150 minutes per week
* Monitor for signs of hypoglycemia and hyperglycemia and seek medical attention if symptoms persist or worsen
* Schedule follow-up appointments with his primary care physician and endocrinologist as scheduled

**Future Care and Follow-up:**

John Doe will be followed up with his primary care physician in 1 week and with his endocrinologist in 2 weeks to monitor his progress and adjust his treatment plan as necessary. He will also receive regular foot examinations to check for signs of peripheral neuropathy and funduscopic examinations to monitor for retinopathy.

**Patient Education:**

John Doe received education on the causes of diabetes, symptoms and signs of hypoglycemia and hyperglycemia, and diabetic complications. He was also advised on the importance of regular physical activity, balanced diet, and medication adherence to manage his diabetes effectively.

**Vaccinations:**

John Doe received vaccinations against Streptococcus pneumoniae, influenza virus, hepatitis B, varicella, and SARS-CoV-2 as recommended for patients with diabetes.

**Conclusion:**

John Doe was diagnosed with type 1 diabetes mellitus and was started on insulin therapy and metformin. He received education on diabetes management and was discharged with a plan for follow-up and ongoing care. The patient will require close monitoring and adjustments to his treatment plan as necessary to manage his diabetes effectively and prevent complications.